ISPO

Molecular Biology

Genetic susceptibility and new therapeutic options for colorectal cancer

Gilles Thomas, MD

Molecular study of an environmental carcinogen

Edward Bresnick PhD

The Wilms tumor suppressor gene WT1: target genes and functional pathways

DA Haber, MD

Telomerase: diagnostic application

Hidetoshi Tahara, PhD

Regulation of p53 stability

Ze'ev Ronai, PhD

Stromal-epithelial interactions dictate prostate cancer androgen-independent metastatic progression

LWK Chung PhD

Tumor promotion pathways and inhibitors

Hirota Fujiki, M.D., Masami Suganuma, Ph.D., Sachiko Okabe, Eisaburo Sueoka, M.D., Kazue Imai, Ph.D. and Kei Nakachi, Ph.D.

Genetic and epigenetic changes of intercellular communication genes during multistage carcino-genesis

H Yamasaki, Y Omori, M-L Zaidan-Dagli, N Mironov, M Mesnil, V Krutovskikh

BAP1: A novel nuclear-localized ubiquitin hydrolase which binds to the BRCA1 RING Finger and enhances BRCA1-mediated tumor suppression

Frank J. Rauscher, III

Disorders in Cell Circuitry in Cancer: Exploitable Targets for Prevention and Therapy

I. Bernard Weinstein, Hirofumi Yamamoto, Edward K-H Han, Alessandro Sgambato, Ping Zhou, Yuichiro Doki, Nadir Arber, and Marco Ciaparrone

An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle check-point control

TD Tlsty, PhD

Matrix metalloproteinases and inhibitors

Patrick Anglard, PhD